The tPSA density was higher in carcinoma than in benign nodular hyperplasia (1.22 vs 0.10); With the tPSA density threshold >0.15, the prostatic carcinoma accounting for 78.4%, then the benign group only 21.6%; the Sensitivity and the Specificity were 82.9% and 77.1% respectively.